Literature DB >> 10921390

Natural history of acute hepatitis C.

E Tanaka1, K Kiyosawa.   

Abstract

To study the short- and long-term outcomes of acute hepatitis C, three groups of patients were enrolled. Of 26 patients with acute hepatitis C, 18 (69%) maintained HCV viraemia and 8 had cleared virus naturally at 12 months after the onset. Normalization of ALT was seen in all 8 patients with acute resolving hepatitis, but in only 1 (5%) of the 18 patients with chronic HCV infection (P< 0.001). Changes in liver histology were analysed in 43 patients with acute hepatitis C who underwent repeated liver biopsy. The mean score of the fibrotic stage was 0.9 within 1 year of the onset, and it increased gradually up to 3.5 at 30 years from the onset (0.1 grade/year). The fibrotic stage increased more rapidly in patients aged more than 50 years. In 115 patients, the mean duration between blood transfusion and the diagnosis of HCC increased significantly (P< 0.001) in accordance with increasing age at blood transfusion; 35 +/- 5.3 years in patients aged less than 30 years, 30 +/- 4.9 years in those aged between 30 and 40 years, and 25 +/- 6.8 years in those aged more than 40 years. In conclusion, approximately 70% of patients with acute hepatitis C develop chronic hepatitis. Once patients develop chronic hepatitic fibrosis of the liver, it progresses over several decades, faster in older patients.

Entities:  

Mesh:

Year:  2000        PMID: 10921390     DOI: 10.1046/j.1440-1746.2000.02112.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  Impact of host responses on control of hepatitis C virus infection in Chinese blood donors.

Authors:  Tingting Li; Zixuan Chen; Jinfeng Zeng; Jingang Zhang; Wenjing Wang; Ling Zhang; Xin Zheng; Lifang Shuai; Paul Klenerman; Jean-Pierre Allain; Chengyao Li
Journal:  Biochem Biophys Res Commun       Date:  2011-10-29       Impact factor: 3.575

2.  Natural interferon alpha treatment and interferon alpha receptor 2 levels in acute hepatitis C.

Authors:  Kazuyuki Ohata; Koji Yano; Hiroshi Yatsuhashi; Manabu Daikoku; Michiaki Koga; Katsumi Eguchi; Michitami Yano
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

3.  Liver fibrosis during an outbreak of acute hepatitis C virus infection in HIV-infected men: a prospective cohort study.

Authors:  Daniel S Fierer; Alison J Uriel; Damaris C Carriero; Arielle Klepper; Douglas T Dieterich; Michael P Mullen; Swan N Thung; M Isabel Fiel; Andrea D Branch
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

4.  Frequent recovery and broad genotype 2 diversity characterize hepatitis C virus infection in Ghana, West Africa.

Authors:  Daniel Candotti; Jillian Temple; Francis Sarkodie; Jean-Pierre Allain
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

5.  NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients.

Authors:  Ahmed El-Shamy; Ikuo Shoji; Wafaa El-Akel; Shymaa E Bilasy; Lin Deng; Maissa El-Raziky; Da-peng Jiang; Gamal Esmat; Hak Hotta
Journal:  J Clin Microbiol       Date:  2012-09-19       Impact factor: 5.948

6.  Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases.

Authors:  Ayumi Sugiura; Satoru Joshita; Yuki Yamashita; Tomoo Yamazaki; Naoyuki Fujimori; Takefumi Kimura; Akihiro Matsumoto; Shuichi Wada; Hiromitsu Mori; Soichiro Shibata; Kaname Yoshizawa; Susumu Morita; Kiyoshi Furuta; Atsushi Kamijo; Akihiro Iijima; Satoko Kako; Atsushi Maruyama; Masakazu Kobayashi; Michiharu Komatsu; Makiko Matsumura; Chiharu Miyabayashi; Tetsuya Ichijo; Aki Takeuchi; Yuriko Koike; Yukio Gibo; Toshihisa Tsukadaira; Hiroyuki Inada; Yoshiyuki Nakano; Seiichi Usuda; Kendo Kiyosawa; Eiji Tanaka; Takeji Umemura
Journal:  Biomedicines       Date:  2020-04-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.